PF-06372865

· Pfizer

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for PF-06372865, covering 2014-08-18 to 2018-03-14. Get the full timeline:

Most recent: Clinical Trial Update: PF-06372865 in Subjects With Photosensitive Epilepsy [Phase 2]